Dialysis is a major financial burden with a large and growing population.
Vascular access is the “lifeline” for hemodialysis patients.1 Vascular access is a major cause of hospitalizations and morbidity in patients with end stage renal disease. Easily obtained and accurate data assessing vascular access could lead to improved outcomes and substantial savings to the healthcare system.
30-50%
of arteriovenous
fistulae fail to
mature6, 7
4x
increase in vascular access
costs per year for patients
with unusable AVF vs.
patients with functional AVF8
80%
of patients initiate
dialysis on a catheter9
57%
of patients who initiate dialysis on a catheter continue to rely on a catheter 6 months later9
2
catheter-based bloodstream infections per catheter per year result in hospitalization10
$23k
average cost per hospitalization
from bloodstream infections10, 11, 12
$160
incremental cost per
catheter per day
compared to patients
with an AVF10, 13, 14, 15
2-3x
greater mortality for patients
with a catheter vs patients
with an AVF16, 17, 18, 19, 20, 21
“Ultrasound should be the first technique of choice in the
evaluation of maturation, regardless of physical examination.” 24
Ultrasound parameters offer predictive value starting at 2-weeks post-op.25
conventional ultrasound requires
expensive equipment, highly
trained personnel and a separate
visit to a vascular lab
for a variety of reasons,
patient compliance is only 12-33%
for visits outside of routine
dialysis sessions26
QUANTIFY
volumetric flow rate, depth and diameter
VISUALIZE
diameter and depth
along fistula
TRACK
flow values
over time
Bioresorbable implant
Custom automated 3D ultrasound
REFERENCES: